BAY 86-4367: Clinical Trials

1 trial of BAY 86-4367, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow BAY 86-4367: new trials by email Literature Review of BAY 86-4367 trials Research Report on BAY 86-4367

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-4367 in Patients With Prostate Cancer and Healthy Volunteers
BAY86-4367 - Diagnostic Imaging
Phase 1TerminatedBayer162009-09-012014-06-26

Conditions studied

Neoplasms (1)

Sponsors

Bayer (1)

Countries

Germany (1)  ·  Switzerland (1)

NIH funding

2008 (1)